Botulinum Toxin Type A Application Experiences in Bolu Abant İzzet Baysal University Neurology Clinic

Basit Öğe Kaydı
dc.contributor.authorTurel, Canan Akünal
dc.date.accessioned2023-04-10T20:31:07Z
dc.date.available2023-04-10T20:31:07Z
dc.date.issued2022
dc.departmentRektörlük, Rektörlüğe Bağlı Birimler, Düzce Üniversitesi Dergilerien_US
dc.description.abstractAim: The aim of this study was to evaluate the effects of different clinical applications of BoNT-A as hemifacial spasm, blepharospasm, cervical dystonia, bruxism, head tremor and spasticity in stroke, Multiple Sclerosis (MS), spinal trauma, hereditary spastic paraplegia, cerebral palsy, and chronic migraine. Material and Methods: In this retrospective study, which was conducted between January 2019 and December 2021, 79 patients with movement disorders, spasticity, and chronic migraine monitored in our clinic and whose BoNT-A injections were applied were included. The diagnosis and treatment, side effects encountered in therapy, follow-up during the treatment, and the response to the treatment evaluated subjectively by patients were discussed. Results: The improvement in patients' response to treatment was subjectively reported by themselves. The improvement in the response of the patients to the treatment subjectively stated that improvement of 60% and above was taken as good, improvement between 59-40% moderate, and improvement of 39% and below bad. Accordingly, 78.94% of the patients subjectively stated improvement as good, 13.15% as moderate, and 7.89% as bad. Although the incidence of complications was 9.21%, these side effects were mild and transient in all of the patients and did not cause any of the patients to discontinue the treatment. Conclusion: The results were statistically significant and consistent with the literature. This study supports the fact that botulinum toxin therapy is effective and safe for HS, BS, cervical dystonia, spasticity, bruxism, head tremor, and chronic migraine.en_US
dc.identifier.doi10.33631/sabd.1052875
dc.identifier.endpage406en_US
dc.identifier.issn2792-0542
dc.identifier.issue3en_US
dc.identifier.startpage401en_US
dc.identifier.trdizinid1124733en_US
dc.identifier.urihttp://doi.org/10.33631/sabd.1052875
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1124733
dc.identifier.urihttps://hdl.handle.net/20.500.12684/12071
dc.identifier.volume12en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofSağlık Bilimlerinde Değer (Online)
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBotulinum Toxinen_US
dc.subjectblefpharospasmen_US
dc.subjectdystoniaen_US
dc.subjecthemifacial spasmen_US
dc.subjectspasticityen_US
dc.titleBotulinum Toxin Type A Application Experiences in Bolu Abant İzzet Baysal University Neurology Clinicen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
12071.pdf
Boyut:
581.19 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Sağlık Bilimlerinde Değer (Online) Koleksiyonu